Tag: Investors
ROSEN, A Prime Ranked Law Business, Encourages SelectQuote, Inc. Investors to Protected Counsel In advance of Crucial October 15 Deadline in Securities Course Action – SLQT | National News
NEW YORK, Sept. 5, 2021 /PRNewswire/ — WHY: Rosen Legislation Firm, a world-wide trader legal rights regulation organization, reminds purchasers of the securities of SelectQuote, Inc. (NYSE: SLQT) among February 8, 2021 and Might 11, 2021, inclusive (the “Class Period of time”), of the important October 15, 2021 lead plaintiff deadline. SO WHAT: If you obtained
ROSEN, A International AND Leading Regulation Organization, Encourages Orphazyme A/S Investors with Losses to Safe Counsel Before Essential Deadline in Securities Course Action – ORPH | Countrywide News
NEW YORK, Aug. 29, 2021 /PRNewswire/ — WHY: Rosen Legislation Organization, a world wide trader rights law agency, reminds purchasers of the securities of Orphazyme A/S (NASDAQ: ORPH): (1) pursuant and/or traceable to Orphazyme’s September 29, 2020 first public providing (the “IPO” or “Featuring”) and/or (2) in between September 29, 2020 and June 18, 2021, inclusive,
ROSEN, A Foremost Trader Legal rights Legislation Company, Encourages CarLotz, Inc. Investors with Losses to Safe Counsel Prior to Crucial September 7 Deadline in Securities Class Motion – LOTZ, LOTZW | 2021-08-27 | Press Releases
NEW YORK, Aug. 27, 2021 /PRNewswire/ — WHY: Rosen Legislation Company, a world trader rights legislation business, reminds purchasers of the securities of CarLotz, Inc. (NASDAQ: LOTZ, LOTZW) among December 30, 2020 and May possibly 25, 2021, inclusive (the “Class Period”), of the vital September 7, 2021 lead plaintiff deadline. SO WHAT: If you acquired
ROSEN, A Major Ranked Legislation Agency, Encourages Athira Pharma, Inc. Investors to Secure Counsel In advance of Essential August 24 Deadline in Securities Course Action – ATHA | 2021-08-13 | Push Releases
NEW YORK, Aug. 13, 2021 /PRNewswire/ — WHY: Rosen Law Organization, a international trader rights legislation company, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or traceable to the Company’s preliminary general public supplying executed in September 2020 (the “IPO” or “Providing”) and/or (b) concerning September 18, 2020 and June
